CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets of $4.34 million as of 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Additional Information
us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets · last filed 2026-02-18
- 2025-12-27: Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets $4.34M.
- 2024-12-28: Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets $3.55M.
- 2023-12-30: Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets $3.50M.
- 2022-12-31: Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets $3.11M.
| Period end | Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets |
|---|---|
| 2025-12-27 | $4.34M 10-K · filed 2026-02-18 |
| 2024-12-28 | $3.55M 10-K · filed 2026-02-18 |
| 2023-12-30 | $3.50M 10-K · filed 2025-02-19 |
| 2022-12-31 | $3.11M 10-K · filed 2024-02-14 |
| 2021-12-25 | $19.50M 10-K · filed 2023-02-22 |
| 2020-12-26 | $18.56M 10-K · filed 2022-02-16 |
| 2019-12-28 | $343.69M 10-K · filed 2021-02-17 |
| 2018-12-29 | $213.25M 10-K · filed 2020-02-11 |
| 2017-12-30 | $292.15M 10-K · filed 2019-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |